Docking simulations, synthesis, and anti-inflammatory activity evaluation of 2-(N-alkyl)amino-3-nitroimidazo[1,2-a]pyridines

Medicinal Chemistry Research

Volumn 21, Issue 6, 2012, Pages 775-782

  Márquez Flores, Yazmín K ^a   Campos Aldrete, Ma Elena ^a   Salgado Zamora, Héctor ^a   Correa Basurto, José ^a   Meléndez Camargo, Ma Estela ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Anti inflammatory; Cyclooxygenase; Docking; Imidazo 1,2 a pyridines

Indexed keywords

2 (N ALKYL)AMINO 3 NITROIMIDAZO[1,2 A]PYRIDINE; 2 (N ALKYL)AMINO 3 NITROIMIDAZO[1,2 A]PYRIDINE DERIVATIVE; 2 (N BENZYL)AMINO 3 NITROIMIDAZO[1,2 A]PYRIDINE; 2 (N CYCLOPROPYL)AMINO 3 NITROIMIDAZO[1,2 A]PYRIDINE; 2 (N DIISOPROPYL)AMINO 3 NITROIMIDAZO[1,2 A]PYRIDINE; 3 NITROIMIDAZO[1,2 A]PYRIDINE 2 CARBONITRILE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; IMIDAZO[1,2 A]PYRIDINE DERIVATIVE; INDOMETACIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; GRANULOMA; MOLECULAR DOCKING; NONHUMAN; RAT;

EID: 84861918771     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-011-9585-5     Document Type: Article

References (32)

1. Akaho E, Fujikawa C, Runion HI, Hill CR, Nakano H (1999) A study on binding modes of nonsteroidal anti-inflammatory drugs to COX-1 and COX-2 as obtain by Dock4.0. J Chem Soft 5(3):147-162
2. Almirante L, Mugnaini A, Rugarli P, Gamba A, Zefelippo E, De Toma N, Murmann W (1968) Derivatives IF imidazole. III. Synthesis and pharmacological activities of nitriles, amides, and carboxylic acid derivatives of imidazo[1, 2-a]pyridine. J Med Chem 12:122-126
3. Arias L, Salgado-Zamora H, Cervantes H, Campos E, Reyes A, Taylos E (2006) Some nucleophilic substitutions in 2-cyano-3-nitroimidazol [1,2-α] pyridine. J Heteroc Chem 43(3):565-569 (Pubitemid 43865633)
4. Banchero P, Giachetto G, Telechea H, Speranza N, Seade C (2004) Seguridad de los inhibidores selectivos de la ciclooxigenasa 2. Rev Med Urug 20:136-144
5. Biftu T, Feng D, Fisher M, Liang G, Qian X, Scribner A, Dennis R, Lee S, Liberator PA, Brown C, Gurnett A, Leavitt PS, Thompson D, Mathew J, Misura A, Samaras S, Tamas T, Sina JF, McNulty KA, McKnight CG, Schmatz DM, Wyvratt M (2006) Synthesis and SAR studies of very potent imidazopyridine antiprotozoal agents. Bioorg Med Chem 16:2479-2483
6. C-Basurto J, Aburtos J, T-Ferrara J, Torres E (2007) Ligand recognition by chloroperoxidase using molecular interaction fields and quantum chemistry calculations. Mol Simul 33(8): 649-654 (Pubitemid 47301159)
7. Chandrasekharan NV, Simmons DL (2004) The cyclooxygenases. Genome Biol 5:241.1-241.7
8. Davies NM, Good RL, Roupe KA, Yáñez JA (2004) Cyclooxygenase- 3: axiom, dogma, anomaly, enigma or splice error?-not as easy as 1, 2, 3. J Pharm Sci 7(2):217-226
9. Dilber SP, Dobric SL, Juranic ZD, Markovic BD, Vladimirov SM, Juranic IO (2008) Docking studies and anti-inflammatory activity of β-hidroxy-β- arylpropanoic acids. MOLEFW 13:603-615
10. Felcy FG, Lakshminarasimhan D, Vasantha P, Kuppuswamy N (2001) Cyclooxygenase-2-an attractive target for fruitful drug design. Curr Sci 80(1):26-34
11. Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Zakrzewski VG, Montgomery JA, Stratmann RE, Burant JC, Dapprich S, Millam JM, Daniels AD, Kudin KN, Strain MC, Farkas O, Tomasi J, Barone V, Cossi M, Cammi R, Mennucci B, Pomelli C, Adamo C, Clifford S, Ochterski J, Peterson GA, Ayala PY, Cui Q, Morokuma K, Malick DK, Rabuck AD, Raghavachari K, Foresman JB, Cioslowski J, Ortiz JV, Baboul AG, Stefanov BB, Liu G, Liashenko A, Piskorz P, Komaromi I, Gomperts R, Martin RL, Fox DJ, Keith T, Al-Laham MA, Peng CY, Nanayakkara A, Challacombe M, Gill PMW, Johnson B, Chen W, Wong MW, Andres JL, Gonzalez C, Head-Gordon M, Replogle ES, Pople JA (1998) Gaussian 98, Revision A.9. Gaussian, Inc., Pittsburgh
12. Hayakawa M, Kaizawa H, Kawaguchi K, Ishikawa N, Koizumi T, Ohishi T, Yamano M, Okada M, Ohta M, Tsukamoto S, Raynaud FI, Waterfield MD, Parker P, Workman P (2007) Synthesis and biological evaluation of imidazo[1, 2-α]pyridine derivates as novel PI3 kinase p110α inhibitors. Bioorg Med Chem 15:403-412 (Pubitemid 44738565)
13. Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14:33-38 (Pubitemid 26152973)
14. Kaapro A, Ojanen J (2002) Protein docking. http://www.lce.hut.fi/ teaching/S-114.500/k2002/Protdock.pdf. Accessed 5 Oct 2009
15. Kaminski JJ, Doweyko AM (1997) Antiulcer agents 6. Analysis of the in vitro biochemical and in vivo gastric antisecretoru activity of substituted imidazo[1, 2-a]pyridines and related analogues using comparative molecular field analysis and hypothetical active site lattice methodologies. J Med Chem 40:427-436 (Pubitemid 27080021)
16. Kumar V, Abbas AK, Fausto N (2005) Patología estructural y funcional, 7th edn edn. Elsevier, España, pp 48-117
17. Kunanusorn P, Teekachunhatean S, Sangdee C, Panthong A (2009) Antinociceptive and anti-inflammatory activities of a Chinese herbal recipe (DJW) in animal models. Int J Appl Res Nat Prod 2(1):1-8
18. Lacerda RB, de Lima CKF, da Silva LL, Romeiro NC, Miranda ALP, Barreiro EJ, Fraga CAM (2009) Discovery of novel analgesic and anti-inflammatory 3-arylamine-imidazo[1, 2-α]pyridine symbiotic prototypes. Bioorg Med Chem 17:74-84
19. Lhassani M, Chavignon O, Chezal J, Teulade J, Chapat J, Snoeck R, Andre G, Balzarini J, de Clercq E, Gueiffier A (1999) Synthesis and antiviral activity of imidazo[1, 2-a]pyridines. Eur J Med Chem 34:271-274
20. Márquez-Flores YK, Montellano-Rosales H, Campos-Aldrete ME, Meléndez-Camargo ME (2009) Anti-inflammatory activity of aqueous and methanolic extracts of Oenothera rosea L0Hér. ex Ait in the rat. Rev Mex Cien Farm 40(3):11-16
21. Maruyama Y, Anami K, Terasawa M, Goto K, Imayoshi T, Kadobe Y, Mizushima Y (1981) Anti-inflammatory activity of an imidazopyridine derivative (miroprofen). Arzneim Forsch 31(7):1111-1118 (Pubitemid 12247946)
22. 2 synthase-2 in membranes. J Biol Chem 281(38):28354-28364 (Pubitemid 44414549)
23. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19:1639
24. Padilla ZAJ, Rojo DA (2002) Simulación del reconocimiento entre proteínas y moléculas orgánicas o docking. Aplicación al diseño de fármacos. Mensaje Bioquím 26:129-145
25. PDB. Protein Data Bank. http://www.pdb.org/pdb/home/home.do.Accessed 9 Sept 2009
26. Penning TD, Chandrakumar NS, Desai BN, Djuric SW, Gasiecki AF, Malecha JW, Miyashiro JM, Russell MA, Askonas LJ, Gierse JK, Harding EI, Highkin MK, Kachur JF, Kim SH, Villani-Price D, Pyla EY, Ghoreishi-Haack NS, Smith WG (2003) Synthesis of imidazopyridines and purines as potent inhibitors of leukotriene A4 hydrolase. Bioorg Med Chem Lett 13:1137-1139 (Pubitemid 36331817)
27. Pradilla VOE (2004) Ciclooxigenasa 3: La nueva iso-enzima en la familia. MedUNAM 7(21):181-184
28. Rajeswari R, Thejomoorthy P, Mathuram LN, Narayana RKVS (2006) Anti-inflammatory activity of Cassia Fistula Linn. Bark extracts in sub-acute models of inflammation in rats. Vet Anim Sci 2(5):193-199
29. Rether J, Erkel G, Anke T, Bajtner J, Sterner O (2008) Imidazo[1, 2-a]pyridine derivates as inhibitors of TNF-α expression in T cells. Bioorg Med Chem 16:1236-1241 (Pubitemid 351191779)
30. Secretaría de Agricultura, Ganadería, Desarrollo Rural, Pesca y Alimentación (1999) Technical specifications for the production, care and use of laboratory animals. Official Mexican Standard. NOM-062.ZOO
31. Teulade JC, Grassy G, Girard JP, Chapat JP, De Buoochberg MS (1978) Antibactériens dérives de la nitro-3 imidazo [1,2-a] pyridine. Synthése et relation structure-activité "in vitro". Eur J Med Chem 13(3):271-276 (Pubitemid 8365523)
32. Thejomoorthy P, Narayana RKVS (2007) Studies on anti inflammatory and analgesic activity of Seendil Chooranam-a Siddha drug. Vet Anim Sci 3(2):78-82